Suppr超能文献

第三次肾移植排斥反应发作应在何时进行治疗?

When should the third renal transplant rejection episode be treated?

作者信息

Matas A J, Simmons R L, Kjellstrand C M, Fryd D S, Najarian J S

出版信息

Ann Surg. 1977 Jul;186(1):104-10. doi: 10.1097/00000658-197707000-00015.

Abstract

Recent reports cite better survival when repeatedly rejecting renal allografts are removed and patients returned to hemodialysis. However, the criteria for graft removal remain undefined; although some reports recommend removing all kidneys undergoing a third rejection. In our series (1968-1973) of 316 patients with technically successful first grafts followed 2(1/2)-8 years, graft survival was inversely related to the number of rejection episodes. One hundred per cent of kidneys without rejection are currently functioning or functioned at the time of death compared to 90% with one rejection, 67.4% with two and 21% with three. However, 40% of kidneys having three rejection episodes functioned longer than one year after treatment of the third rejection episode. In an attempt to determine the predictability of one year graft survival or failure following treatment of the third rejection, a formula was developed that correctly predicted in 33 of 38 (87%) patients. The formula was based on information available prior to treatment of the third rejection episode, and represents an index of baseline renal function (serum creatinine after second rejection episode) and two indices of the severity of rejection episodes (serum creatinine change between the first and second rejection episodes; rapidity of sequential rejection).Following its derivation, the formula was applied to a second group (1974) of 19 patients having had three rejection episodes. The formula correctly predicted one year allograft survival or failure following treatment of the third rejection episode in 68% of these patients. A striking finding of our review was a significant difference in current patient survival between those having no rejection episodes (89%) and those having one or more rejection episodes (65%) (p < .00001). There was no significantly greater long-term curtailment in survival if more than one rejection eipsode was treated. Patients having one rejection eipsode seemed to die from varying causes and at varying time periods. Patients dying after two or more rejection episodes had an increased incidence of deaths due to bacterial infection.

摘要

近期报告指出,当反复排斥的肾移植受者移除移植肾并恢复血液透析时,其生存率更高。然而,移植肾移除的标准仍不明确;尽管一些报告建议移除所有经历第三次排斥的肾脏。在我们的系列研究(1968 - 1973年)中,316例首次移植技术成功的患者随访了2.5 - 8年,移植肾存活率与排斥发作次数呈负相关。目前,无排斥反应的移植肾100%仍在发挥功能或在患者死亡时仍有功能,相比之下,经历一次排斥的移植肾为90%,经历两次排斥的为67.4%,经历三次排斥的为21%。然而,40%经历三次排斥发作的移植肾在第三次排斥发作治疗后功能维持超过一年。为了确定第三次排斥发作治疗后移植肾一年存活或失败的可预测性,我们制定了一个公式,该公式在38例患者中的33例(87%)中做出了正确预测。该公式基于第三次排斥发作治疗前可得的信息,代表了基线肾功能指标(第二次排斥发作后的血清肌酐)以及两个排斥发作严重程度指标(第一次和第二次排斥发作之间的血清肌酐变化;连续排斥的速度)。该公式推导出来后,应用于第二组(1974年)19例经历三次排斥发作的患者。该公式在68%的此类患者中正确预测了第三次排斥发作治疗后移植肾一年的存活或失败情况。我们综述的一个显著发现是,无排斥发作的患者(89%)与有一次或多次排斥发作的患者(65%)当前的患者生存率存在显著差异(p <.00001)。如果治疗不止一次排斥发作,在长期生存方面并没有明显更大的缩减。经历一次排斥发作的患者似乎死于各种原因且时间各异。经历两次或更多次排斥发作后死亡的患者因细菌感染导致的死亡发生率增加。

相似文献

8
Acute rejection episodes and long-term transplant function.
Arch Surg. 1979 May;114(5):574-8. doi: 10.1001/archsurg.1979.01370290024004.

本文引用的文献

3
Pulmonary complications in transplant recipients.
Arch Surg. 1972 Aug;105(2):260-8. doi: 10.1001/archsurg.1972.04180080112019.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验